(5S)-3-(1,2-dihydropyrazin-6-yl)-5-[[2-(6-fluoro-4,8-dimethyl-3-oxoquinoxalin-5-yl)oxyethylamino]methyl]-1,3-oxazolidin-2-one

C20H23FN6O4 — CID 175057120

IUPAC(5S)-3-(1,2-dihydropyrazin-6-yl)-5-[[2-(6-fluoro-4,8-dimethyl-3-oxoquinoxalin-5-yl)oxyethylamino]methyl]-1,3-oxazolidin-2-one
SMILESCc1cc(F)c(OCCNC[C@H]2CN(C3=CN=CCN3)C(=O)O2)c2c1ncc(=O)n2C
InChIInChI=1S/C20H23FN6O4/c1-12-7-14(21)19(18-17(12)25-10-16(28)26(18)2)30-6-5-23-8-13-11-27(20(29)31-13)15-9-22-3-4-24-15/h3,7,9-10,13,23-24H,4-6,8,11H2,1-2H3/t13-/m0/s1
InChIKeyUUDIKCGECANSQH-ZDUSSCGKSA-N
MW430.44 g/mol
LogP0.64
Rot. Bonds7

About (5S)-3-(1,2-dihydropyrazin-6-yl)-5-[[2-(6-fluoro-4,8-dimethyl-3-oxoquinoxalin-5-yl)oxyethylamino]methyl]-1,3-oxazolidin-2-one

(5S)-3-(1,2-dihydropyrazin-6-yl)-5-[[2-(6-fluoro-4,8-dimethyl-3-oxoquinoxalin-5-yl)oxyethylamino]methyl]-1,3-oxazolidin-2-one (PubChem CID 175057120) has the molecular formula C20H23FN6O4 and a molecular weight of 430.44 g/mol. Its IUPAC name is (5S)-3-(1,2-dihydropyrazin-6-yl)-5-[[2-(6-fluoro-4,8-dimethyl-3-oxoquinoxalin-5-yl)oxyethylamino]methyl]-1,3-oxazolidin-2-one.

Molecular Properties

Compound Name(5S)-3-(1,2-dihydropyrazin-6-yl)-5-[[2-(6-fluoro-4,8-dimethyl-3-oxoquinoxalin-5-yl)oxyethylamino]methyl]-1,3-oxazolidin-2-one
PubChem CID175057120
Molecular FormulaC20H23FN6O4
Molecular Weight430.44 g/mol
Exact Mass430.18
IUPAC Name(5S)-3-(1,2-dihydropyrazin-6-yl)-5-[[2-(6-fluoro-4,8-dimethyl-3-oxoquinoxalin-5-yl)oxyethylamino]methyl]-1,3-oxazolidin-2-one
SMILESCc1cc(F)c(OCCNC[C@H]2CN(C3=CN=CCN3)C(=O)O2)c2c1ncc(=O)n2C
InChIInChI=1S/C20H23FN6O4/c1-12-7-14(21)19(18-17(12)25-10-16(28)26(18)2)30-6-5-23-8-13-11-27(20(29)31-13)15-9-22-3-4-24-15/h3,7,9-10,13,23-24H,4-6,8,11H2,1-2H3/t13-/m0/s1
InChIKeyUUDIKCGECANSQH-ZDUSSCGKSA-N
XLogP0.64
TPSA110.08 Ų
H-Bond Donors2
H-Bond Acceptors9
Rotatable Bonds7
Heavy Atoms31
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500430.44
LogP ≤ 50.64
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 109

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Analyze (5S)-3-(1,2-dihydropyrazin-6-yl)-5-[[2-(6-fluoro-4,8-dimethyl-3-oxoquinoxalin-5-yl)oxyethylamino]methyl]-1,3-oxazolidin-2-one with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

(5S)-3-(1,2-dihydropyrazin-6-yl)-5-[[2-[7-fluoro-1-(2-methoxyethyl)-2-oxoquinolin-8-yl]ethylamino]methyl]-1,3-oxazolidin-2-one
CID 175400098
(5S)-5-[[2-[1-[2-[tert-butyl(dimethyl)silyl]oxyethyl]-7-fluoro-2-oxoquinolin-8-yl]ethylamino]methyl]-3-(1,2-dihydropyrazin-6-yl)-1,3-oxazolidin-2-one
CID 175400112
(5S)-3-(1,2-dihydropyrazin-6-yl)-5-[[2-[7-fluoro-1-(2-hydroxyethyl)-2-oxoquinolin-8-yl]ethylamino]methyl]-1,3-oxazolidin-2-one
CID 175400091
6-[(5S)-5-[[2-(6-fluoro-4-methyl-3-oxoquinoxalin-5-yl)oxyethylamino]methyl]-2-oxo-1,3-oxazolidin-3-yl]-4H-pyrazino[2,3-b][1,4]oxazin-3-one
CID 142601127
6-[(5S)-5-[[2-(6-fluoro-4-methyl-3-oxoquinoxalin-5-yl)oxyethylamino]methyl]-2-oxo-1,3-oxazolidin-3-yl]-4H-pyrazino[2,3-b][1,4]oxazin-3-one;methane;sulfane
CID 159146316
6-[(5S)-5-[[2-(7-fluoro-1,4-dimethyl-2-oxoquinolin-8-yl)oxyethylamino]methyl]-2-oxo-1,3-oxazolidin-3-yl]-4H-pyrazino[2,3-b][1,4]oxazin-3-one
CID 155162513
2-[(5S)-5-[4-(6-fluoro-4,8-dimethyl-3-oxoquinoxalin-5-yl)oxybutyl]-2-oxo-1,3-oxazolidin-3-yl]-8H-pyrano[2,3-b]pyrazin-7-one;sulfane
CID 159362853
6-[5-[2-[2-(7-fluoro-1,4-dimethyl-2-oxoquinolin-8-yl)oxyethylamino]ethyl]-2-oxo-1,3-oxazolidin-3-yl]-4H-pyrazino[2,3-b][1,4]oxazin-3-one
CID 142601074
(5R)-5-(azidomethyl)-3-(1,2-dihydropyrazin-6-yl)-1,3-oxazolidin-2-one
CID 175054795
6-[(5S)-5-[[2-[(3-chloro-5-methyl-6-oxo-1,5-naphthyridin-4-yl)oxy]ethylamino]methyl]-2-oxo-1,3-oxazolidin-3-yl]-4H-pyrazino[2,3-b][1,4]oxazin-3-one;sulfane
CID 157360078
(5S)-5-[[2-(7-chloro-4-methyl-3-oxopyrido[2,3-b]pyrazin-6-yl)oxyethylamino]methyl]-3-(3-methylidene-4H-pyrazino[2,3-b][1,4]oxazin-6-yl)-1,3-oxazolidin-2-one
CID 159886948
6-[(5S)-5-[[2-[(5-methyl-6-oxo-1,5-naphthyridin-4-yl)oxy]ethylamino]methyl]-2-oxo-1,3-oxazolidin-3-yl]-4H-pyrido[3,2-b][1,4]oxazin-3-one
CID 142601110

Frequently Asked Questions

What is the IUPAC name of (5S)-3-(1,2-dihydropyrazin-6-yl)-5-[[2-(6-fluoro-4,8-dimethyl-3-oxoquinoxalin-5-yl)oxyethylamino]methyl]-1,3-oxazolidin-2-one?
The IUPAC name of (5S)-3-(1,2-dihydropyrazin-6-yl)-5-[[2-(6-fluoro-4,8-dimethyl-3-oxoquinoxalin-5-yl)oxyethylamino]methyl]-1,3-oxazolidin-2-one (CID 175057120) is (5S)-3-(1,2-dihydropyrazin-6-yl)-5-[[2-(6-fluoro-4,8-dimethyl-3-oxoquinoxalin-5-yl)oxyethylamino]methyl]-1,3-oxazolidin-2-one.
What is the SMILES notation for (5S)-3-(1,2-dihydropyrazin-6-yl)-5-[[2-(6-fluoro-4,8-dimethyl-3-oxoquinoxalin-5-yl)oxyethylamino]methyl]-1,3-oxazolidin-2-one?
The canonical SMILES for (5S)-3-(1,2-dihydropyrazin-6-yl)-5-[[2-(6-fluoro-4,8-dimethyl-3-oxoquinoxalin-5-yl)oxyethylamino]methyl]-1,3-oxazolidin-2-one is Cc1cc(F)c(OCCNC[C@H]2CN(C3=CN=CCN3)C(=O)O2)c2c1ncc(=O)n2C.
What is the InChIKey of (5S)-3-(1,2-dihydropyrazin-6-yl)-5-[[2-(6-fluoro-4,8-dimethyl-3-oxoquinoxalin-5-yl)oxyethylamino]methyl]-1,3-oxazolidin-2-one?
The InChIKey is UUDIKCGECANSQH-ZDUSSCGKSA-N. The full InChI is InChI=1S/C20H23FN6O4/c1-12-7-14(21)19(18-17(12)25-10-16(28)26(18)2)30-6-5-23-8-13-11-27(20(29)31-13)15-9-22-3-4-24-15/h3,7,9-10,13,23-24H,4-6,8,11H2,1-2H3/t13-/m0/s1.
What are the key properties of (5S)-3-(1,2-dihydropyrazin-6-yl)-5-[[2-(6-fluoro-4,8-dimethyl-3-oxoquinoxalin-5-yl)oxyethylamino]methyl]-1,3-oxazolidin-2-one?
(5S)-3-(1,2-dihydropyrazin-6-yl)-5-[[2-(6-fluoro-4,8-dimethyl-3-oxoquinoxalin-5-yl)oxyethylamino]methyl]-1,3-oxazolidin-2-one has a molecular weight of 430.44 g/mol, XLogP of 0.64, 7 rotatable bonds, 2 hydrogen bond donors, and 9 hydrogen bond acceptors.
Where does this data come from?
All data for (5S)-3-(1,2-dihydropyrazin-6-yl)-5-[[2-(6-fluoro-4,8-dimethyl-3-oxoquinoxalin-5-yl)oxyethylamino]methyl]-1,3-oxazolidin-2-one is sourced from PubChem (CID 175057120), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).